29 Sep 10
If you have been looking around for a CV writing service you will have noticed that prices vary considerably and may be wondering why. The CV & Interview Advisors (that’s us) were one of the early entrants into the world of CV writing and have been around for many years.
Matt Craven
29 Sep 10
Over the last few years, many companies have started to offer CV appraisals to the extent that the market is now flooded with offers of free advice. I remember the days when we and one or two other CV writing companies offered such a service and it became a very effective way of building relationships with customers and strutting our expertise on all things CV related.
Matt Craven
29 Sep 10
There has been some conjecture amongst professionals regarding the merits of a personal profile on a CV. This conjecture stems from the fact that many job seekers fill there personal profiles with irrelevant and mostly clichéd information.
Matt Craven
29 Sep 10
In my capacity as a Career Consultant, I have worked closely with freelancers & contractors for many years and two challenges keep rearing their ugly head: Firstly, how does a freelancer write a CV that isn’t six pages long; and secondly, what happens if you want to apply for a role that draws upon skills gained in a contract that isn’t the most recent piece of work that you have done.
Matt Craven
24 Sep 10
In a climate of fiscal hardship, everybody has a special case to plead. Indeed, when the funding scalpel is out, every department and almost every recipient of public sector funds has a special tale to tell. The truth is, science funding really is that important.
Max Golby
20 Sep 10
If you have written material for a journal like this one, or a book, we may be holding monies due to you.
James Davis
16 Sep 10
As healthcare innovation produces new treatments, and new information delivers increased awareness, a substantial rise in prescription drug use is only to be expected. For the most part, this can largely be seen as a positive development.
Max Golby
09 Sep 10
Potentially lifesaving science should not be marginalized to the status of a political football. Yet for so many years in the United States, that’s exactly what stem cell science has become.
Max Golby
07 Sep 10
A new book by Rebecca J. Anderson
Mike Wood
06 Sep 10
Last week, leaders from companies like AstraZeneca, GlaxoSmithKline, Pfizer and Roche met in Vienna in a closed meeting to discuss the future of the pharma industry. Fears of layoffs at pharmaceutical companies are once again dominating the news, but could there be a less painful way to save money?
Emma Naylor
02 Sep 10
Even in the good years, mental health budgets were seldom in line with what experts expected or deemed necessary. Thus, in times of budget deficits and scathing public expenditure cuts, the worry becomes even greater. For those that care most about the health service then, the Coalition government's decision to ring fence healthcare spending has been largely applauded.
Max Golby
25 Aug 10
Originally born under the Conservatives, but fully evolved under Labour, Private Finance Initiatives (PFIs) essentially offered the NHS an alternative way of paying for new hospitals and renovations at a time when public capital was said to be limited.
Max Golby
23 Aug 10
While long prohibited under UK ABPI regulations, if you’ve worked in the world of big pharma in the U.S., you’ll have seen it all a hundred times. A drugs company sponsors a medical conference, they pay for the meals and flights of the delegates and they hand them all a goodie bag as they leave.
Max Golby
20 Aug 10
The role of a seasoned pharmacist has some obvious kind of benefits attached with it. This basically includes the role that they play and the kind of work carried out by them including learning the trade from a well-known lead pharmacist.
Jane Jones
12 Aug 10
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.
Cancer Research UK
30 Jul 10
We have a fundamental problem with our health service. It's bloated, it's weighed down in bureaucracy and it's terribly inefficient. That's if you believe the diagnosis of our health service by the new Health Secretary, Andrew Lansley.
Max Golby
23 Jul 10
If the nation’s recruiters received a pound for every time they’d interviewed a candidate that looked good on paper but disappointed in practice, there’d currently be an awful lot of recruiters in the process of relocating to the Caribbean.
Max Golby / Mike Wood
22 Jul 10
Back in May, it was announced that new stem cell research would reduce the need for animal testing. Now, we are really beginning to see the benefits of groundbreaking science that is not reliant on out dated methods of testing.
Emma Naylor
20 Jul 10
Skin cancers come in various forms but the type which causes most fear is the malignant melanoma, derived from the pigment-forming cells of the skin or melanocytes.
Dr Laurence Lever
19 Jul 10
During a time of major economic downturn, there are few industries that can be said to be truly ‘recession proof’. Yet for years now, big pharma has largely been seen as precisely that. After all, no matter dire the markets, and no matter how low consumer confidence plummets, there is always a demand for healthcare.
Max Golby
25 Jun 10
In areas such as competition policy and choice in the NHS, there could be said to be much correlation between the approaches of both governments past and present. Yet in other key areas of policy, there are unquestionably examples of ideological, or at least philosophical, differences in outlook. Or at least in theory.
Max Golby
18 Jun 10
A selective memory is a wonderful thing. That is, if you're a conspiracy theorist or an opportunistic critic of any kind. Yet, for those of us with memories of a more consistent mold, a lot of the current and decidedly harsh criticism directed against the World Health Organization’s handling of the just passed H1N1 'Swine Flu' outbreak must be questioned in kind.
Max Golby
17 Jun 10
As the new Conservative-led coalition finally begins to settle down to the task ahead, questions of policy detail are increasingly replacing the brouhaha of election-time buccaneering and healthcare policy and the NHS are no exceptions to the rule – particularly in the case of competition policy.
Max Golby
28 May 10
With every challenge comes a new opportunity. Indeed, if we are to believe the results of a recent international workforce survey by Kelly Services, while the global economic recession has produced troubles a plenty, it has also evoked a new found sense of entrepreneurialism as workers look to adjust to changing employment models and to respond to new challenges in a very human way.
Max Golby
28 May 10
Just five years after its formation through the merger of Fujisawa and Yamanouchi, Astellas has become one of the top 20 pharmaceutical companies in the world. Employing 15,000 people and with annual sales reaching €1,287 million in Europe, Astellas has exceeded all expectations for growth in the past five years and the company’s management team has devised a clear vision to ensure that this success continues in the years to come.
Astellas Pharma
20 May 10
Economic uncertainty has fueled a growing trend toward self-employment and entrepreneurialism with one-in-five respondents worldwide now working outside the traditional employment relationship, and 50 percent saying that they would like to do so, according to the latest survey results from workforce solutions leader Kelly Services®.
Editor
13 May 10
Researchers at Weill Cornell Medical Center in New York have demonstrated that a reovirus therapy called REOLYSIN works synergistically with gemcitabine and may be worth further investigation.
Janet Vasquez
23 Apr 10
The theme for National Stop Snoring Week 2010 is all about our houses. From house dust mites to pet dogs it seems that our houses are minefields when it comes to snoring. Nobody is safe as there are dangers lurking in every room.
Marianne Davey - The British Snoring & Sleep Apnoea Association (BSSAA)
22 Apr 10
Karolinska Institutet is one of the world´s leading medical universities. Its mission is to contribute to the improvement of human health through research and education. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Alex Heeley - De Facto Communications
14 Apr 10
Parents of babies and young children suffering from conditions such as asthma and eczema will be relieved to know there is a breakthrough product available that can drastically reduce their child’s misery and symptoms.
Kaleidoscope Communications